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Abstract Electrospinning is a long-known polymer pro-
cessingtechniquethathasreceivedmoreinterestandattention
in recent years due to its versatility and potential use in the
ﬁeld of biomedical research. The fabrication of three-dimen-
sional (3D) electrospun matrices for drug delivery and tissue
engineering is of particular interest. In the present study, we
identiﬁed optimal conditions to generate novel electrospun
polymeric scaffolds composed of poly-D/L-lactide and poly-
L-lactide in the ratio 50:50. Scanning electron microscopic
analyses revealed that the generated poly(D/L-lactide-co-
L-lactide) electrospun hybrid microﬁbers possessed a unique
porous high surface area mimicking native extracellular
matrix (ECM). To assess cytocompatibility, we isolated der-
mal ﬁbroblasts from human skin biopsies. After 5 days of in
vitro culture, the ﬁbroblasts adhered, migrated and prolifer-
atedonthe newlycreated3Dscaffolds.Our datademonstrate
the applicability of electrospun poly(D/L-lactide-co-L-lactide)
scaffolds to serve as substrates for regenerative medicine
applications with special focus on skin tissue engineering.
1 Introduction
The process to form synthetic ﬁbers between 3 nm and
5 lm in diameter by drawing material out of a ﬁne nozzle
using electrostatic forces, designated as electrospinning,
has been known for many decades [1, 2]. In the last
10 years the interest in electrospinning as a potential
polymer processing technique for applications in drug
delivery and tissue engineering increased tremendously
[2–5]. The multidisciplinary ﬁeld of tissue engineering
applies the principles of engineering and life sciences with
the aim to generate biological substitutes that restore,
maintain or improve tissue and organ function [6]. Tissue
engineering approaches utilize (I) living cells or cell sub-
stitutes to replace damaged cells; (II) the delivery of tissue-
inducing substances, such as growth and differentiation
factors, to targeted locations; and (III) scaffold-based
concepts that involve the combination of viable cells, bio-
molecules and three-dimensional (3D) scaffolds [6–12].
However, the applicability of either isolated cells or tissue-
inducingsubstancesislimitedtodefectsthataresmallinsize
orthatarewellcontained.Therefore,themaininterestliesin
the third approach—the use of cell-seeded 3D scaffolds.
Requirements for an optimal scaffold are the ability to
allow cells to proliferate and migrate, to synthesize their
own extracellular matrix (ECM) and to ultimately facilitate
the formation of a functional tissue or organ [5, 8, 13]. As a
complex microenvironment, the natural ECM consists of
ﬁbrous and soluble proteins as well as other bioactive
molecules and displays a 3D topography [5, 14]. The
electrospinning process permits the generation of ﬁbrous
scaffolds that exhibit a 3D nano- or microtopography with
a high porosity similar to the natural ECM [1, 8, 11, 13, 15,
16]. Due to their ﬂexibility in material selection, as well as
the ability to easily control scaffold properties, electrospun
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applications. One of the most important substrate proper-
ties is to support cell adhesion and growth. Several studies
have shown that cells including epidermal ﬁbroblasts,
keratinocytes, chondrocytes, smooth muscle cells, cardio-
myocytes and adult stem cells adhered and proliferated
well when cultured on electrospun scaffolds [17–20].
Due to their excellent biocompatibility and biodegrad-
ability, polylactides, polyglycolides and their copolymers
are used in a wide range of biomedical applications. Spe-
ciﬁcally, polylactides derived from lactic acid will degrade
in the human body via a hydrolytic reaction, ﬁrst producing
oligomers and then lactic acids, of which the L-lactic acid is
a natural intermediate in metabolism [21, 22]. Of particular
interest when focusing on a clinical application, pure
poly(L-lactide) and copolymers such as poly(D/L-lactide-
co-L-lactide), among few other synthetic polymers, are
presently approved by the Food and Drug Administration
for clinical applications [23–25].
In the present study, we aimed to generate novel elec-
trospun polymeric scaffolds that can ultimately serve either
as in vitro skin model for wound dressing applications [26]
or as a synthetic dermal graft. Since it had been previously
shown that porous scaffolds composed of either poly-D/
L-lactide or poly-L-lactide provide favorable growth and
proliferation conditions for various cells [27], we generated
a suitable copolymer made of these polymers for our
experiments. The properties of this kind of polymeric
biomaterial can differ in a wide range according to the ratio
of the used D-, L- and D/L-lactide for polymerization and
their resulting molecular weights. It has been shown that
varying compositions of lactides have an impact on the
biodegradability as well as on the physical and mechanical
properties of a biomaterial [28]. Accordingly, pure poly-
L-lactides show a high crystallinity and mechanical stabil-
ity while having a low degradability rate. To enhance their
degradability by hydrolysis, D/L-lactides can be introduced
into the polymer, increasing the presence of amorphous
regions accompanied with a lower crystallinity. Here we
selected a suitable linear copolymer, showing a sufﬁcient
balance between degradation properties and mechanical
stability, which could be used in the electrospinning pro-
cess for the creation of non-woven biomechanically stable
and cytocompatible scaffolds. The particular random
poly(D/L-lactide-co-L-lactide) employed in this study had a
50:50 L-lactide:D/L-lactide mole ratio with a molecular
weight of approximately 102,000. To produce microﬁbers
of the described speciﬁc polymer via electrospinning,
chloroform was determined as the most appropriate sol-
vent. To achieve an optimal balance between ﬁber strength,
permeability and cell adhesion, porous ﬁbers with a
diameter of 4–5 lm were produced, correlating with the
diameter of collagen ﬁbers found in a range of tissues in
vivo [29]. To test cytocompatibility of the electrospun
poly(D/L-lactide-co-L-lactide) scaffolds, we seeded the
constructs with dermal ﬁbroblasts that had been isolated
from human skin biopsies. After 5 days in vitro, we eval-
uated cell viability, proliferation and morphology.
The results of our experiments demonstrate the feasi-
bility to create biomimetic electrospun scaffolds composed
of poly(D/L-lactide-co-L-lactide) that may potentially serve
as a substrate for various soft tissue engineering and
regenerative medicine applications.
2 Materials and methods
2.1 Poly(D/L-lactide-co-L-lactide
A linear poly(D/L-lactide-co-L-lactide) (50:50) copolymer
(Mw = 102,000) was prepared according to a previously
established protocol [30, 31]. Brieﬂy, appropriate amounts
of L-lactide, D/L-lactide (Boehringer KG, Ingelheim,
Germany) and the starter molecule 1,8-octanediol (Sigma–
Aldrich Chemie GmbH, Munich, Germany) were placed
into a reaction ﬂask and the mixture was heated under an
inert nitrogen gas atmosphere to 130C. After complete
melting, stannous 2-ethylhexanoate (0.05 wt% based on
total lactide content; Sigma–Aldrich), which had been
dissolved in dry toluene, was added. The reaction mixture
was stirred until it became solid. After cooling to room
temperature, the polymer was dissolved in dichlorometh-
ane (Sigma–Aldrich), precipitated in methanol and dried in
vacuum. Preliminary cytotoxicity experiments using stan-
dard 3T3 mouse embryonic ﬁbroblasts (LGC Standards
GmbH, Wesel, Germany) indicated the cytocompatibility
of the poly(D/L-lactide-co-L-lactide) material.
2.2 Electrospun ﬁbrous matrices
Tetrahydrofuran, acetone, dichloromethane, hexaﬂuoro-
isopropyl alcohol and chloroform (all Sigma–Aldrich) were
tested for their suitability to dissolve poly(D/L-lactide-L-
lactide) for its subsequent use for electrospinning. We
determined that a 10% (w/w) solution was essential to spin
the copolymer under the conditions described: A homo-
geneous solution was prepared by slow stirring 1.0 g of the
copolymer in 6.1 ml of the solvent at room temperature
for 3 h using a magnetic stirrer at 250 rpm. The obtained
clear and viscous solution was directly transferred into a
5 ml plastic syringe, which was connected to a 0.40 9
25 mm-gaugebluntendedstainless-steelneedle(= spinning
nuzzle). The copolymer solution was then exposed to the
electrospinning process using a custom designed electros-
pinning apparatus consisting of an adjustable high-voltage
power supply with a limited current of 200 lA (ESV-100;
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123Ingenieurbu ¨ro G. Fuhrmann, Leverkusen, Germany). The
glass surface of a mirror (20 9 20 cm
2; glass thickness
3 mm) was selected as collector plate for collecting the
electrospun ﬁbers. The needle and the metallic side of the
mirror were connected to the ESV-100. The syringe was
mounted vertically against the collector and the sample
solution was fed at a constant rate through the syringe to the
needletip.Thedistancebetweentheneedletipandthemirror
was maintained at 20 cm. The voltage applied to the needle
was adjusted to 15 kV. The ﬂow rate of the solution was
controlled between 0.5 to 0.7 ml h
-1. Fiber diameters were
determined by software analysis of microscopic images
(Image-ProPlus5.0, Media Cybernetics,Inc., Silver Spring,
MD, USA).
2.3 In vitro degradation assays
To determine the in vitro degradation of the electrospun
poly(D/L-lactide-L-lactide), we used 80 mg of the electro-
spun material and the same amount of smooth, solid and
non-porous poly(D/L-lactide-L-lactide)-composed controls.
These controls had a thickness of approximately 50–60 lm
and were generated using the same material (poly(D/L-
lactide-L-lactide)–chloroform (50:50) solution) as used for
the electrospinning. All samples were exposed to 5 ml of
simulated body ﬂuid (SBF) medium of pH 7.4 in a ther-
mostatic incubator at 37C over 18 weeks. Every week
1 ml of the SBF was withdrawn and the SBF in the vessel
was replenished up to 5 ml. The degree of degradation was
monitored by the L-lactate sample concentration using
an enzymatic L-lactate assay (R-Biopharm, Darmstadt,
Germany) according to the manufacturer’s protocol.
2.4 Thermogravimetric analysis
In order to conﬁrm that all solvent was evaporated from the
electrospun poly(D/L-lactide-L-lactide), we performed
thermogravimetric analyses at 20–200C with a heating
rate of 20C/min at room temperature as described previ-
ously [32] using a STA 449C Jupiter (Netzsch-Gera ¨tebau
GmbH, Selb, Germany).
2.5 Primary cell isolation and culture
Primary human ﬁbroblasts were isolated from foreskin by
enzymatic treatment. Dermal and epidermal layers were
separated by a 16 h digest in a 2 U/ml dispase solution in
phosphate-buffered saline (PBS; Invitrogen GmbH,
Darmstadt, Germany) at 4C. The dermal layer was cut and
treated for 45 min with 0.45 U/ml collagenase solution
(Invitrogen). Cells were seeded in T-25 culture ﬂasks in
Dulbecco’s Modiﬁed Eagle Medium (DMEM; Invitrogen).
The medium was changed every 2–3 days. Fibroblasts
were used at passage 2–5.
2.6 Cell seeding of the electrospun matrix
After conﬁrming that all solvent was removed from the
electrospun material, the matrices were cut to
1.5 9 1.5 cm
2. All samples were then sterilized using 70%
ethanol solution for 20 min, followed by two washing steps
with PBS. For cell seeding experiments, the electrospun
matrices were placed in a petri dish with a 3.2 cm diam-
eter. On each electrospun scaffold, 250,000 ﬁbroblasts
were seeded in DMEM and cultured for a maximum of
5 days at 37C.
2.7 Cell proliferation assays
After a culture time of 17 h and 5 days, proliferation was
measured using the WST-1 assay (Roche Diagnostics
GmbH, Mannheim, Germany) according to the manufac-
turer’s protocol. Brieﬂy, the WST-1 reagent is a water-
soluble tetrazolium saltthat canbe used forcell proliferation
or cell viability assays. The rate of WST-1 cleavage by
mitochondrial dehydrogenases correlates with the number
of viable cells in the culture. Therefore the assay primarily
detects total enzymatic activities that are able to reduce the
WST-1 substrate. Accordingly, the values obtained using
this assay are a direct measure of cell number and prolif-
eration, provided that cytotoxic effects and reductions in
metabolism can be excluded. Fibroblasts that had been
cultured on 3.2 cm diameter tissue culture polystyrene
(TCPS) petri dishes served as control. The absorbance of
the samples was measured at a wavelength of 450 nm
employing a microtiter plate reader (Model 550; Bio-Rad
Laboratories GmbH, Mu ¨nchen, Germany). All data are
displayed in arbitrary units (a.u.) ± SD.
2.8 Live/dead staining of cells
To assess cytocompatibility, ﬁbroblasts were cultured for
5 days on the electrospun scaffolds, followed by live/dead
staining for 3 min using a solution consisting of 0.005%
(w/v) ﬂuorescein diacetate (FDA, Sigma–Aldrich) (stock
solution: 0.5% (w/v, in acetone), 0.009% (w/v) propidium
iodide (PI, Sigma–Aldrich) (stock solution: 0.1% (w/v) in
PBS) in PBS. Cells were immediately visualized by ﬂuo-
rescence microscopy using a Zeiss Axiovert 200 M Apo-
Tome equipped with the appropriate ﬁlter sets detecting
FITC and rhodamine (Carl Zeiss Microimaging GmbH,
Jena, Germany). Images were processed with Adobe
Photoshop CS3.3 (Adobe Systems Inc., San Jose, CA,
USA).
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All samples were ﬁxed using 2% glutaraldehyde (Sigma–
Aldrich) for 45 min at room temperature, dehydrated with
a series of graded alcohols and air-dried overnight. The
dried samples were sputter coated with platinum and
scanning electron microscopic (SEM) micrographs were
taken with a Zeiss Leo 1520 VP (Carl Zeiss).
Fiber diameters in the electrospun scaffolds were mea-
sured using scanning electron micrographs. The average
ﬁber diameter was determined from the measurements
taken as described before in more detail [13].
2.10 Statistical analyses
Statistical signiﬁcance was assessed by Student’s t test.
P-values less than 0.05 were deﬁned as statistically
signiﬁcant.
3 Results and discussion
Solvents such as tetrahydrofuran and acetone, as well as
halogenated hydrocarbons, including dichloromethane,
chloroform and hexaﬂuoroisopropyl alcohol, were tested
for their suitability to dissolve poly(D/L-lactide-L-lactide)
(50:50) for electrospinning. Chloroform was selected as the
most appropriate solvent due to its superior evaporation
property, resulting in an optimal drying rate during the
spinning process, which prevented that the ﬁbers stuck
together (Fig. 1a, b). An increase ﬁber surface was
achieved while obtaining a unique porous ﬁber surface
structure (Fig. 1b), which is a known phenomenon induced
by phase separation resulting from the rapid evaporation of
the solvent during the electrospinning process [33]. The
average dimension of the obtained electrospun ﬁber
matrices was approximately 10 cm
2. The scaffold thick-
ness ranged between 50 and 100 lm. Scanning electron
microscopy revealed that the generated poly(D/L-lactide-
co-L-lactide) hybrid microﬁbers had an average diameter of
4.26 ± 1.48 lm.
Degradation of polylactides under physiological condi-
tions depends on structural parameters such as molecular
weight, monomer composition (L-, D- and meso-lactide),
degree of branching, but foremost their surface properties
[34]. In order to assess the degradation rate of dense bio-
materials the mass loss is measured over time; however,
this method is not suitable to determine the degradation of
electrospun materials with a low mass and a high surface
area. To date, there are only few data available describing
the hydrolytic degradation of electrospun matrices [22]. No
data are available concerning the degradation of highly
porous poly(D/L-lactide-L-lactide) ﬁbers. In this study, we
attempted to address this problem capturing small amounts
of the degradation products of poly(D/L-lactide-L-lactide)—
L-lactate—using an enzymatic L-lactate assay. To assess
the impact of the topography of the material on degradation
by hydrolysis, enzymatic assays were performed simulta-
neously using the poly(D/L-lactide-co-L-lactide) electrospun
matrices as well as poly(D/L-lactide-L-lactide)-composed
smooth, solid, non-porous controls (Fig. 1c). The results of
the degradation experiments are summarized in Fig. 2.I n
contrast to the controls, electrospun matrices exhibited a
larger surface area, which led to the assumption that the
electrospun material would demonstrate a faster degrada-
tion in aqueous solution. Indeed, we observed that
after 18 weeks, 3.5 mg L-lactate was released from the
Fig. 1 SEM images of poly(D/L-lactide-co-L-lactide)-composed scaf-
folds. a Overview of the generated electrospun poly(D/L-lactide-co-L-
lactide) material. b The electrospun poly(D/L-lactide-co-L-lactide)
ﬁbers have a unique porous surface. c SEM image of smooth, non-
porous and non-ﬁbrous poly(D/L-lactide-L-lactide)-composed controls
Fig. 2 Summary of the results of the degradation assays of electro-
spun poly(D/L-lactide-co-L-lactide) scaffolds in comparison with solid,
poly(D/L-lactide-co-L-lactide)-composed controls
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from the controls; however, this effect was not statistically
signiﬁcant (P = 0.79) and also much lower than expected.
The rate of degradation was only slightly enhanced by the
increased surface. Nevertheless, our data showed that based
on their degradation proﬁle, electrospun poly(D/L-lactide-
co-L-lactide) scaffolds are suitable materials for biomedical
applications.
In order to assess the proliferation behavior of the
ﬁbroblasts we used the WST-1 cell proliferation assay. The
results of the proliferation tests are summarized in Fig. 3.
Brieﬂy, ﬁbroblasts were cultured for either 17 h or 5 days
on smooth control TCPS petri dishes (Fig. 3a) or on the
electrospun poly(D/L-lactide-co-L-lactide) scaffolds
(Fig. 3b). The enzymatic activity of ﬁbroblasts assessed
after 17 h was determined as the starting point of the
experiment and was set to 1 in each sample group. We
found in both the 5-day-TCPS and the 5-day-electrospun
scaffold groups a signiﬁcant increase of the WST-1 con-
version when compared to the cultures after 17 h. Although
our data do not allow the calculation of division rates, they
clearly indicate that an expansion of human dermal ﬁbro-
blasts is possible when cultured on the electrospun poly
(D/L-lactide-co-L-lactide) matrices. Moreover, the 3D sub-
strate obviously allowed prolonged increase in cell num-
bers whereas contact inhibition started earlier at the TCPS
control. Thus, our electrospun substrate composed of the
novel biodegradable polymer poly(D/L-lactide-co-L-lactide)
represents a suitable scaffold material for the cultivation of
primary skin ﬁbroblasts.
To further assess the biocompatibility of the electrospun
poly(D/L-lactide-co-L-lactide) hybrid material we per-
formed live/dead staining. Viable cells were labeled using
ﬂuorescein diacetate, whereas dead cells were identiﬁed by
propidium iodide uptake as displayed in Fig. 4. On both
TCPS, serving here again as control substrate, and elec-
trospun poly(D/L-lactide-co-L-lactide) scaffolds almost all
cells were viable, as depicted by the green ﬂuorescent cells
(Fig. 4a, d; overlay: Fig. 4c, f). Only a few propidium
iodide-labeled dead cells (Fig. 4b, e; overlay: Fig. 4c, f)
could be noted. Although there was no signiﬁcance dif-
ference between the two substrates in regards to cell via-
bility, we observed a difference in the morphological
growth pattern of the ﬁbroblasts. On TCPS, the cells were
closely aligned with an elongated morphology. In contrast,
ﬁbroblasts grown on the 3D electrospun poly(D/L-lactide-
co-L-lactide) matrices displayed a branched morphology
with a more physiological adherence pattern, previously
Fig. 3 WST-1 proliferation tests reveal that ﬁbroblasts that were
grown for 5 days on either TCPS culture ware (a) or on the
electrospun poly(D/L-lactide-co-L-lactide) scaffolds (b) show a sig-
niﬁcant increase in overall activity to reduce WST-1 reagent
reﬂecting increase in cell numbers by proliferation. All data are
displayed in arbitrary units (a.u.) ± SD. * P\0.05 17 h vs. 5 days
on TCPS; ** P\0.05 17 h vs. 5 days on electrospun scaffolds
Fig. 4 Viability assessment of primary human ﬁbroblasts cultured on
TCPS (a–c) and electrospun poly(D/L-lactide-co-L-lactide) (d–f) scaf-
folds after 5 days of culture. A high number of viable green
ﬂuorescent cells was observed on both, TCPS (a, c) and the
electrospun poly(D/L-lactide-co-L-lactide) matrix (c, f). In contrast,
only a small number of red ﬂuorescent nuclei depicting dead cells (see
white arrows) were detected on either TCPS (b, c) or the electrospun
poly(D/L-lactide-co-L-lactide) substrates (e, f). Of note, the morpho-
logical growth pattern of the ﬁbroblasts cultured on TCPS (a) differs
from the 3D scaffolds (d). Cells are branched compared to the ﬂat
elongated morphology on TCPS. All scale bars equal 200 lm. (Color
ﬁgure online)
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123noted as the typical shape of migrating ﬁbroblasts in 3D
ﬁbrous scaffolds or matrices [35, 36]. These observations
conﬁrm the results of the WST-1 proliferation tests in
which ﬁbroblasts expanded signiﬁcantly on the electrospun
scaffolds from 17 h to 5 days of culture.
The interaction of the ﬁbroblasts with the electrospun
poly(D/L-lactide-co-L-lactide) scaffolds was further exam-
ined by SEM (Fig. 5). Dermal human ﬁbroblasts were
found evenly distributed throughout the entire scaffold.
SEM images further revealed that the ﬁbroblasts interacted
directly with several ﬁbers as shown by the formation of
long cytoplasmic branches, a phenomenon that was also
observed by F. Grinnell in 2008 [37]. These numerous long
branches help cells monitor their extracellular environment
and may also be involved in the migration of cells through
the electrospun scaffold.
4 Conclusions
In this study, poly(D/L-lactide-co-L-lactide) hybrid microﬁ-
bers of lower molecular weight and high porosity were
successfully prepared by electrospinning. We have shown
that our novel electrospun poly(D/L-lactide-L-lactide) sub-
stratesareappropriatematricestocultureandexpandhuman
dermal ﬁbroblasts. The engineered ﬁbrous network offers
room for the migration of ﬁbroblasts, which is also an
important property of the extracellular space of these cells
within their physiological environment. We provided evi-
dence for cell migration and proliferation, and showed
biological acceptability of the substrate indicated by a
branched,morephysiologicalmorphologyoftheﬁbroblasts.
Theresultsofourlong-termdegradationstudiessuggestthat
the electrospun non-woven matrices could be potentially
used for applications in skin tissue engineering.
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